Center for Molecular Imaging Research; Department of Radiology
Adenocarcinoma; Animals; Cell Line, Tumor; Colonic Neoplasms; Erythrocyte Volume; Humans; Indazoles; Magnetic Resonance Angiography; Mice; Mice, Nude; Neovascularization, Pathologic; imaging; Phosphorylation; Protein Kinase Inhibitors; Vascular Endothelial Growth Factor Receptor-2; inhibitors; Xenograft Model Antitumor Assays
Antiangiogenesis is emerging as efficient strategy for targeting and potentially eliminating neoplastic tumor vessels. The main goal of this study was to establish whether absolute tumor blood volume (V(b)) change could be used as an early predictor of antiangiogenesis in ectopic and orthotopic colon carcinomas. To assess therapy-induced changes of V(b), we did comparative analysis of signal intensities in tumors and muscle using steady-state magnetic resonance imaging (MRI) assisted with an intravascular paramagnetic contrast agent [gadolinium-labeled protected graft copolymer (PGC-Gd)]. Athymic mice with implanted human MV522 tumors were treated with vascular endothelial growth factor type 2 receptor tyrosine kinase inhibitor (VEGFR2-TKI) that has been shown to inhibit VEGFR2 phosphorylation and tumor growth in vivo. Animals were imaged either after a single day or after a 1-week course of treatments. The measured V(b) in ectopic tumors was 2.5 +/- 1.5% of total tissue volume 1 week after the implantation (n = 8). Two doses of VEGFR2-TKI (25 mg/kg, p.o., b.i.d.) resulted in a decrease of V(b) to 1.3 +/- 0.3%. In orthotopic tumors, the measured V(b) was initially higher (11.9 +/- 2.0%); however, VEGFR2-TKI treatment also resulted in a statistically significant decrease of V(b). The absolute V(b) was not affected in the muscle as a result of treatments. MRI measurements were corroborated by using isotope and correlative histology experiments. Our results show that steady-state MRI is highly sensitive to early antiangiogenic effects caused by small molecule drugs.
DOI of Published Version
Cancer Res. 2005 Oct 15;65(20):9253-60. Link to article on publisher's site
Kim YR, Yudina A, Figueiredo J, Reichardt W, Hu-Lowe DD, Petrovsky A, Kang H, Torres D, Mahmood U, Weissleder R, Bogdanov AA. (2005). Detection of early antiangiogenic effects in human colon adenocarcinoma xenografts: in vivo changes of tumor blood volume in response to experimental VEGFR tyrosine kinase inhibitor. Open Access Publications by UMMS Authors. https://doi.org/10.1158/0008-5472.CAN-03-2619. Retrieved from https://escholarship.umassmed.edu/oapubs/349